Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Number of holders
-
146
-
Total 13F shares, excl. options
-
42,685,949
-
Shares change
-
+4,570,632
-
Total reported value, excl. options
-
$1,154,889,575
-
Value change
-
+$143,231,958
-
Put/Call ratio
-
95%
-
Number of buys
-
80
-
Number of sells
-
-60
-
Price
-
$27.06
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q1 2018
183 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q1 2018.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 146 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42,685,949 shares
of 80,437,135 outstanding shares and own 53.07% of the company stock.
Largest 10 shareholders include SCOPIA CAPITAL MANAGEMENT LP (5,914,052 shares), RTW INVESTMENTS, LP (4,137,960 shares), BlackRock Inc. (3,281,710 shares), VANGUARD GROUP INC (2,960,664 shares), Boxer Capital, LLC (2,600,000 shares), D. E. Shaw & Co., Inc. (2,333,603 shares), STATE STREET CORP (2,161,406 shares), GREAT POINT PARTNERS LLC (1,539,822 shares), FMR LLC (1,115,354 shares), and WELLINGTON MANAGEMENT GROUP LLP (817,240 shares).
This table shows the top 146 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.